{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:44:44Z","timestamp":1770691484519,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK56338"],"award-info":[{"award-number":["DK56338"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA125123"],"award-info":[{"award-number":["CA125123"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ES030285"],"award-info":[{"award-number":["ES030285"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP110532"],"award-info":[{"award-number":["RP110532"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP150578"],"award-info":[{"award-number":["RP150578"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP170719"],"award-info":[{"award-number":["RP170719"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP170005"],"award-info":[{"award-number":["RP170005"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["1P42ES0327725"],"award-info":[{"award-number":["1P42ES0327725"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013920","name":"VHL Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013920","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gilson Longenbaugh Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Loss of primary cilia in cells deficient for the tumor suppressor <jats:italic>von Hippel Lindau<\/jats:italic> (<jats:italic>VHL<\/jats:italic>) arise from elevated Aurora Kinase A (AURKA) levels. VHL in its role as an E3 ubiquitin ligase targets AURKA for degradation and in the absence of <jats:italic>VHL<\/jats:italic>, high levels of AURKA result in destabilization of the primary cilium. We identified NVP-BEZ235, a dual PI3K\/AKT and mTOR inhibitor, in an image-based high throughput screen, as a small molecule that restored primary cilia in <jats:italic>VHL<\/jats:italic>-deficient cells. We identified the ability of AKT to modulate AURKA expression at the transcript and protein level. Independent modulation of AKT and mTOR signaling decreased AURKA expression in cells confirming AURKA as a new signaling node downstream of the PI3K cascade. Corroborating these data, a genetic knockdown of <jats:italic>AKT<\/jats:italic> in cells deficient for <jats:italic>VHL<\/jats:italic> rescued the ability of these cells to ciliate. Finally, inhibition of AKT\/mTOR using NVP-BEZ235 was efficacious in reducing tumor burden in a 786-0 xenograft model of renal cell carcinoma. These data highlight a previously unappreciated signaling node downstream of the AKT\/mTOR pathway via AURKA that can be targeted in <jats:italic>VHL<\/jats:italic>-null cells to restore ciliogenesis.<\/jats:p>","DOI":"10.1038\/s41598-021-89933-7","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T10:04:53Z","timestamp":1621245893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells"],"prefix":"10.1038","volume":"11","author":[{"given":"Pratim","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimuthu","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reid T.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tia","family":"Talley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durga Nand","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Sung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Coarfa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruhee","family":"Dere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"89933_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cell.2018.02.020","volume":"173","author":"TJ Mitchell","year":"2018","unstructured":"Mitchell, T. J. et al. Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal. Cell 173, 611\u2013623.e617. https:\/\/doi.org\/10.1016\/j.cell.2018.02.020 (2018).","journal-title":"Cell"},{"key":"89933_CR2","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan, M. et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science (New York, NY) 292, 464\u2013468. https:\/\/doi.org\/10.1126\/science.1059817 (2001).","journal-title":"Science (New York, NY)"},{"key":"89933_CR3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ncb1912","volume":"11","author":"CR Thoma","year":"2009","unstructured":"Thoma, C. R. et al. VHL loss causes spindle misorientation and chromosome instability. Nat. Cell Biol. 11, 994\u20131001. https:\/\/doi.org\/10.1038\/ncb1912 (2009).","journal-title":"Nat. Cell Biol."},{"key":"89933_CR4","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1158\/0008-5472.CAN-13-2040","volume":"74","author":"MP Hell","year":"2014","unstructured":"Hell, M. P., Duda, M., Weber, T. C., Moch, H. & Krek, W. Tumor suppressor VHL functions in the control of mitotic fidelity. Cancer Res. 74, 2422\u20132431. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2040 (2014).","journal-title":"Cancer Res."},{"key":"89933_CR5","doi-asserted-by":"publisher","first-page":"6903","DOI":"10.1158\/0008-5472.CAN-06-0501","volume":"66","author":"MS Lutz","year":"2006","unstructured":"Lutz, M. S. & Burk, R. D. Primary cilium formation requires von hippel-lindau gene function in renal-derived cells. Cancer Res. 66, 6903\u20136907. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-0501 (2006).","journal-title":"Cancer Res."},{"key":"89933_CR6","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1681\/ASN.2006020181","volume":"17","author":"MA Esteban","year":"2006","unstructured":"Esteban, M. A., Harten, S. K., Tran, M. G. & Maxwell, P. H. Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein. J. Am. Soc. Nephrol. 17, 1801\u20131806. https:\/\/doi.org\/10.1681\/ASN.2006020181 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"89933_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41581-019-0116-9","volume":"15","author":"Z Anvarian","year":"2019","unstructured":"Anvarian, Z., Mykytyn, K., Mukhopadhyay, S., Pedersen, L. B. & Christensen, S. T. Cellular signalling by primary cilia in development, organ function and disease. Nat. Rev. Nephrol. 15, 199\u2013219. https:\/\/doi.org\/10.1038\/s41581-019-0116-9 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"89933_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fcell.2018.00008","volume":"6","author":"G Wheway","year":"2018","unstructured":"Wheway, G., Nazlamova, L. & Hancock, J. T. Signaling through the primary cilium. Front. Cell Dev. Biol. 6, 8. https:\/\/doi.org\/10.3389\/fcell.2018.00008 (2018).","journal-title":"Front. Cell Dev. Biol."},{"key":"89933_CR9","doi-asserted-by":"publisher","first-page":"113906","DOI":"10.1016\/j.bcp.2020.113906","volume":"175","author":"E Peixoto","year":"2020","unstructured":"Peixoto, E., Richard, S., Pant, K., Biswas, A. & Gradilone, S. A. The primary cilium: Its role as a tumor suppressor organelle. Biochem. Pharmacol. 175, 113906. https:\/\/doi.org\/10.1016\/j.bcp.2020.113906 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"89933_CR10","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/j.ddmec.2013.03.004","volume":"10","author":"T Seeger-Nukpezah","year":"2013","unstructured":"Seeger-Nukpezah, T., Little, J. L., Serzhanova, V. & Golemis, E. A. Cilia and cilia-associated proteins in cancer. Drug Discov. Today Disease Mech. 10, e135\u2013e142. https:\/\/doi.org\/10.1016\/j.ddmec.2013.03.004 (2013).","journal-title":"Drug Discov. Today Disease Mech."},{"key":"89933_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040907","author":"A Adamiok-Ostrowska","year":"2020","unstructured":"Adamiok-Ostrowska, A. & Piekielko-Witkowska, A. Ciliary genes in renal cystic diseases. Cells https:\/\/doi.org\/10.3390\/cells9040907 (2020).","journal-title":"Cells"},{"key":"89933_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2046-2530-2-6","volume":"2","author":"SG Basten","year":"2013","unstructured":"Basten, S. G. & Giles, R. H. Functional aspects of primary cilia in signaling, cell cycle and tumorigenesis. Cilia 2, 6. https:\/\/doi.org\/10.1186\/2046-2530-2-6 (2013).","journal-title":"Cilia"},{"key":"89933_CR13","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cell.2007.04.035","volume":"129","author":"EN Pugacheva","year":"2007","unstructured":"Pugacheva, E. N., Jablonski, S. A., Hartman, T. R., Henske, E. P. & Golemis, E. A. HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell 129, 1351\u20131363. https:\/\/doi.org\/10.1016\/j.cell.2007.04.035 (2007).","journal-title":"Cell"},{"key":"89933_CR14","doi-asserted-by":"publisher","first-page":"e38838","DOI":"10.1371\/journal.pone.0038838","volume":"7","author":"T Seeger-Nukpezah","year":"2012","unstructured":"Seeger-Nukpezah, T. et al. The centrosomal kinase Plk1 localizes to the transition zone of primary cilia and induces phosphorylation of nephrocystin-1. PLoS ONE 7, e38838. https:\/\/doi.org\/10.1371\/journal.pone.0038838 (2012).","journal-title":"PLoS ONE"},{"key":"89933_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ejcb.2012.03.009","volume":"91","author":"C Spalluto","year":"2012","unstructured":"Spalluto, C., Wilson, D. I. & Hearn, T. Nek2 localises to the distal portion of the mother centriole\/basal body and is required for timely cilium disassembly at the G2\/M transition. Eur. J. Cell Biol. 91, 675\u2013686. https:\/\/doi.org\/10.1016\/j.ejcb.2012.03.009 (2012).","journal-title":"Eur. J. Cell Biol."},{"key":"89933_CR16","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","volume":"13","author":"SR Datta","year":"1999","unstructured":"Datta, S. R., Brunet, A. & Greenberg, M. E. Cellular survival: A play in three Akts. Genes Dev. 13, 2905\u20132927. https:\/\/doi.org\/10.1101\/gad.13.22.2905 (1999).","journal-title":"Genes Dev."},{"key":"89933_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature04869","volume":"441","author":"RJ Shaw","year":"2006","unstructured":"Shaw, R. J. & Cantley, L. C. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441, 424\u2013430. https:\/\/doi.org\/10.1038\/nature04869 (2006).","journal-title":"Nature"},{"key":"89933_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj, G. & Manning, B. D. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat. Rev. Cancer 20, 74\u201388. https:\/\/doi.org\/10.1038\/s41568-019-0216-7 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"89933_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning, B. D. & Toker, A. AKT\/PKB signaling: Navigating the network. Cell 169, 381\u2013405. https:\/\/doi.org\/10.1016\/j.cell.2017.04.001 (2017).","journal-title":"Cell"},{"key":"89933_CR20","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/emboj.2008.96","volume":"27","author":"IJ Frew","year":"2008","unstructured":"Frew, I. J. et al. pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation. EMBO J. 27, 1747\u20131757. https:\/\/doi.org\/10.1038\/emboj.2008.96 (2008).","journal-title":"EMBO J."},{"key":"89933_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic, S. et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell 173, 581-594.e512. https:\/\/doi.org\/10.1016\/j.cell.2018.03.057 (2018).","journal-title":"Cell"},{"key":"89933_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/ng.427","volume":"41","author":"M Jacoby","year":"2009","unstructured":"Jacoby, M. et al. INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse. Nat. Genet. 41, 1027\u20131031. https:\/\/doi.org\/10.1038\/ng.427 (2009).","journal-title":"Nat. Genet."},{"key":"89933_CR23","doi-asserted-by":"publisher","first-page":"e9239","DOI":"10.1371\/journal.pone.0009239","volume":"5","author":"R Dere","year":"2010","unstructured":"Dere, R., Wilson, P. D., Sandford, R. N. & Walker, C. L. Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. PLoS ONE 5, e9239. https:\/\/doi.org\/10.1371\/journal.pone.0009239 (2010).","journal-title":"PLoS ONE"},{"key":"89933_CR24","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/ncb2117","volume":"12","author":"C Boehlke","year":"2010","unstructured":"Boehlke, C. et al. Primary cilia regulate mTORC1 activity and cell size through Lkb1. Nat. Cell Biol. 12, 1115\u20131122. https:\/\/doi.org\/10.1038\/ncb2117 (2010).","journal-title":"Nat. Cell Biol."},{"key":"89933_CR25","first-page":"91","volume":"2","author":"RT Sherpa","year":"2016","unstructured":"Sherpa, R. T., Atkinson, K. F., Ferreira, V. P. & Nauli, S. M. Rapamycin increases length and mechanosensory function of primary cilia in renal epithelial and vascular endothelial cells. Int. Educ. Res. J. 2, 91\u201397 (2016).","journal-title":"Int. Educ. Res. J."},{"key":"89933_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1681\/ASN.2013090984","volume":"26","author":"R Dere","year":"2015","unstructured":"Dere, R., Perkins, A. L., Bawa-Khalfe, T., Jonasch, D. & Walker, C. L. beta-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma. J. Am. Soc. Nephrol. 26, 553\u2013564. https:\/\/doi.org\/10.1681\/ASN.2013090984 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"89933_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.495","author":"E Hasanov","year":"2017","unstructured":"Hasanov, E. et al. Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL. Oncogene https:\/\/doi.org\/10.1038\/onc.2016.495 (2017).","journal-title":"Oncogene"},{"key":"89933_CR28","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.219923","author":"P Chowdhury","year":"2018","unstructured":"Chowdhury, P. et al. Bexarotene\u2014A novel modulator of AURKA and the primary cilium in VHL-deficient cells. J. Cell Sci. https:\/\/doi.org\/10.1242\/jcs.219923 (2018).","journal-title":"J. Cell Sci."},{"key":"89933_CR29","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","volume":"7","author":"SM Maira","year":"2008","unstructured":"Maira, S. M. et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol. Cancer Ther. 7, 1851\u20131863. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0017 (2008).","journal-title":"Mol. Cancer Ther."},{"key":"89933_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1083\/jcb.201511055","volume":"216","author":"JM Dyson","year":"2017","unstructured":"Dyson, J. M. et al. INPP5E regulates phosphoinositide-dependent cilia transition zone function. J. Cell Biol. 216, 247\u2013263. https:\/\/doi.org\/10.1083\/jcb.201511055 (2017).","journal-title":"J. Cell Biol."},{"key":"89933_CR31","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1242\/jcs.046276","volume":"122","author":"D Zhu","year":"2009","unstructured":"Zhu, D., Shi, S., Wang, H. & Liao, K. Growth arrest induces primary-cilium formation and sensitizes IGF-1-receptor signaling during differentiation induction of 3T3-L1 preadipocytes. J. Cell Sci. 122, 2760\u20132768. https:\/\/doi.org\/10.1242\/jcs.046276 (2009).","journal-title":"J. Cell Sci."},{"key":"89933_CR32","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.1038\/onc.2017.208","volume":"36","author":"SE Conduit","year":"2017","unstructured":"Conduit, S. E. et al. A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma. Oncogene 36, 5969\u20135984. https:\/\/doi.org\/10.1038\/onc.2017.208 (2017).","journal-title":"Oncogene"},{"key":"89933_CR33","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/ncb1579","volume":"9","author":"CR Thoma","year":"2007","unstructured":"Thoma, C. R. et al. pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nat. Cell Biol. 9, 588\u2013595. https:\/\/doi.org\/10.1038\/ncb1579 (2007).","journal-title":"Nat. Cell Biol."},{"key":"89933_CR34","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1002\/ijc.22154","volume":"119","author":"H Yang","year":"2006","unstructured":"Yang, H., He, L., Kruk, P., Nicosia, S. V. & Cheng, J. Q. Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Int. J. Cancer 119, 2304\u20132312. https:\/\/doi.org\/10.1002\/ijc.22154 (2006).","journal-title":"Int. J. Cancer"},{"key":"89933_CR35","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/onc.2008.434","volume":"28","author":"AA Dar","year":"2009","unstructured":"Dar, A. A., Belkhiri, A. & El-Rifai, W. The aurora kinase A regulates GSK-3beta in gastric cancer cells. Oncogene 28, 866\u2013875. https:\/\/doi.org\/10.1038\/onc.2008.434 (2009).","journal-title":"Oncogene"},{"key":"89933_CR36","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41589-018-0081-9","volume":"14","author":"HJ Donnella","year":"2018","unstructured":"Donnella, H. J. et al. Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer. Nat. Chem. Biol. 14, 768\u2013777. https:\/\/doi.org\/10.1038\/s41589-018-0081-9 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"89933_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature12222","volume":"499","author":"Cancer Genome Atlas Research Network","year":"2013","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43\u201349. https:\/\/doi.org\/10.1038\/nature12222 (2013).","journal-title":"Nature"},{"key":"89933_CR38","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ng.2699","volume":"45","author":"Y Sato","year":"2013","unstructured":"Sato, Y. et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet. 45, 860\u2013867. https:\/\/doi.org\/10.1038\/ng.2699 (2013).","journal-title":"Nat. Genet."},{"key":"89933_CR39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ccr.2007.02.006","volume":"11","author":"JD Gordan","year":"2007","unstructured":"Gordan, J. D., Bertout, J. A., Hu, C. J., Diehl, J. A. & Simon, M. C. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11, 335\u2013347. https:\/\/doi.org\/10.1016\/j.ccr.2007.02.006 (2007).","journal-title":"Cancer Cell"},{"key":"89933_CR40","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/sj.emboj.7600196","volume":"23","author":"M Koshiji","year":"2004","unstructured":"Koshiji, M. et al. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 23, 1949\u20131956. https:\/\/doi.org\/10.1038\/sj.emboj.7600196 (2004).","journal-title":"EMBO J."},{"key":"89933_CR41","doi-asserted-by":"publisher","first-page":"14723","DOI":"10.1074\/jbc.RA118.002800","volume":"293","author":"SJ Bautista","year":"2018","unstructured":"Bautista, S. J. et al. mTOR complex 1 controls the nuclear localization and function of glycogen synthase kinase 3beta. J. Biol. Chem. 293, 14723\u201314739. https:\/\/doi.org\/10.1074\/jbc.RA118.002800 (2018).","journal-title":"J. Biol. Chem."},{"key":"89933_CR42","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/sj.onc.1209990","volume":"26","author":"X Wan","year":"2007","unstructured":"Wan, X., Harkavy, B., Shen, N., Grohar, P. & Helman, L. J. Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26, 1932\u20131940. https:\/\/doi.org\/10.1038\/sj.onc.1209990 (2007).","journal-title":"Oncogene"},{"key":"89933_CR43","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science (New York, NY) 307, 1098\u20131101. https:\/\/doi.org\/10.1126\/science.1106148 (2005).","journal-title":"Science (New York, NY)"},{"key":"89933_CR44","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1158\/1078-0432.CCR-09-3022","volume":"16","author":"DC Cho","year":"2010","unstructured":"Cho, D. C. et al. The efficacy of the novel dual PI3-kinase\/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma. Clin. Cancer Res. 16, 3628\u20133638. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-3022 (2010).","journal-title":"Clin. Cancer Res."},{"key":"89933_CR45","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1634\/theoncologist.2016-0145","volume":"21","author":"MI Carlo","year":"2016","unstructured":"Carlo, M. I. et al. A phase Ib study of BEZ235, a dual inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR), in patients with advanced renal cell carcinoma. Oncologist 21, 787\u2013788. https:\/\/doi.org\/10.1634\/theoncologist.2016-0145 (2016).","journal-title":"Oncologist"},{"key":"89933_CR46","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.prp.2018.04.001","volume":"214","author":"D Fatehi","year":"2018","unstructured":"Fatehi, D., Soltani, A. & Ghatrehsamani, M. SRT1720, a potential sensitizer for radiotherapy and cytotoxicity effects of NVB-BEZ235 in metastatic breast cancer cells. Pathol. Res. Pract. 214, 889\u2013895. https:\/\/doi.org\/10.1016\/j.prp.2018.04.001 (2018).","journal-title":"Pathol. Res. Pract."},{"key":"89933_CR47","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3892\/or.2018.6457","volume":"40","author":"N Alqurashi","year":"2018","unstructured":"Alqurashi, N., Hashimi, S. M., Alowaidi, F., Ivanovski, S. & Wei, M. Q. Dual mTOR\/PI3K inhibitor NVPBEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4EBP1. Oncol. Rep. 40, 1083\u20131092. https:\/\/doi.org\/10.3892\/or.2018.6457 (2018).","journal-title":"Oncol. Rep."},{"key":"89933_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25102454","author":"CC Yu","year":"2020","unstructured":"Yu, C. C., Huang, S. Y., Chang, S. F., Liao, K. F. & Chiu, S. C. The synergistic anti-cancer effects of NVP-BEZ235 and regorafenib in hepatocellular carcinoma. Molecules https:\/\/doi.org\/10.3390\/molecules25102454 (2020).","journal-title":"Molecules"},{"key":"89933_CR49","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103221","author":"X Ye","year":"2020","unstructured":"Ye, X. et al. PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth in vitro and in vivo. Aging (Albany, NY) https:\/\/doi.org\/10.18632\/aging.103221 (2020).","journal-title":"Aging (Albany, NY)"}],"updated-by":[{"DOI":"10.1038\/s41598-021-97270-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89933-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89933-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89933-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T08:31:23Z","timestamp":1670056283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89933-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["89933"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-89933-7","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-021-97270-y","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-97270-y","URL":"https:\/\/doi.org\/10.1038\/s41598-021-97270-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10461"}}